Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 2/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.48 |
| ▸ | MEN1 | O00255 | 3/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 3/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4262686 | 0.85 | KMT2A (0.48) | L3MBTL1MEN1KMT2APOLBMAPT | |
| SCHEMBL5046734 | 0.84 | MAPT (0.45) | L3MBTL1MEN1KMT2AMAPTALDH1A1 | |
| SCHEMBL4250581 | 0.84 | KMT2A (0.58) | L3MBTL1MEN1KMT2APOLBMAPT | |
| SCHEMBL4267095 | 0.83 | MAPT (0.54) | PTGS2L3MBTL1MEN1KMT2APOLB | |
| SCHEMBL2116437 | 0.82 | PTGS2 (0.66) | PTGS2L3MBTL1MEN1KMT2APOLB | |
| SCHEMBL4264041 | 0.81 | PTGS2 (0.48) | PTGS2L3MBTL1MEN1KMT2APOLB | |
| SCHEMBL810052 | 0.81 | HDAC1 (0.45) | GAAALDH2 | |
| SCHEMBL4268398 | 0.81 | CYP4F2 (0.51) | L3MBTL1MEN1KMT2APOLBMAPT | |
| SCHEMBL9856571 | 0.81 | ALDH1A1 (0.50) | PTGS2L3MBTL1MEN1KMT2APOLB | |
| SCHEMBL5046746 | 0.80 | RECQL (0.48) | L3MBTL1POLBMAPTALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7902319-B2 | Unsymmetrical aromatic ether diacids and absorbable polymers therefrom | BEZWADA BIOMEDICAL, LLC (US) | 2011-03-08 | — | — | US | disclosed |
| US-7902319-B2 | Unsymmetrical aromatic ether diacids and absorbable polymers therefrom | BEZWADA BIOMEDICAL, LLC (US) | 2011-03-08 | — | — | US | disclosed |
| US-7902319-B2 | Unsymmetrical aromatic ether diacids and absorbable polymers therefrom | BEZWADA BIOMEDICAL, LLC (US) | 2011-03-08 | — | — | US | disclosed |
| US-20100113592-A1 | UNSYMMETRICAL AROMATIC ETHER DIACIDS AND ABSORBABLE POLYMERS THEREFROM | BEZWADA BIOMEDICAL, LLC (US) | 2010-05-06 | — | — | US | disclosed |
| US-20100113592-A1 | UNSYMMETRICAL AROMATIC ETHER DIACIDS AND ABSORBABLE POLYMERS THEREFROM | BEZWADA BIOMEDICAL, LLC (US) | 2010-05-06 | — | — | US | disclosed |
| US-20100113592-A1 | UNSYMMETRICAL AROMATIC ETHER DIACIDS AND ABSORBABLE POLYMERS THEREFROM | BEZWADA BIOMEDICAL, LLC (US) | 2010-05-06 | — | — | US | disclosed |
| US-7671168-B2 | Unsymmetrical aromatic ether diacids and absorbable polymers therefrom | BEZWADA BIOMEDICAL, LLC (US) | 2010-03-02 | — | — | US | disclosed |
| US-7671168-B2 | Unsymmetrical aromatic ether diacids and absorbable polymers therefrom | BEZWADA BIOMEDICAL, LLC (US) | 2010-03-02 | — | — | US | disclosed |
| US-7671168-B2 | Unsymmetrical aromatic ether diacids and absorbable polymers therefrom | BEZWADA BIOMEDICAL, LLC (US) | 2010-03-02 | — | — | US | disclosed |
| US-20070141113-A1 | UNSYMMETRICAL AROMATIC ETHER DIACIDS AND ABSORBABLE POLYMERS THEREFROM | BEZWADA BIOMEDICAL, LLC (US) | 2007-06-21 | — | — | US | disclosed |
| US-20070141113-A1 | UNSYMMETRICAL AROMATIC ETHER DIACIDS AND ABSORBABLE POLYMERS THEREFROM | BEZWADA BIOMEDICAL, LLC (US) | 2007-06-21 | — | — | US | disclosed |
| US-20070141113-A1 | UNSYMMETRICAL AROMATIC ETHER DIACIDS AND ABSORBABLE POLYMERS THEREFROM | BEZWADA BIOMEDICAL, LLC (US) | 2007-06-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100113592-A1 | UNSYMMETRICAL AROMATIC ETHER DIACIDS AND ABSORBABLE POLYMERS THEREFROM | DDT, ACMSD, HPD | PTGS2 2456/4885L3MBTL1 4852/4885MEN1 4250/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.